COLUMBIA, Md., May 29 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK) announced today that it will be presenting at the 8th Annual Needham Life Sciences Conference which is scheduled to take place June 10-11, 2009 at the New York Palace Hotel in New York City. Peter L. Buzy, Chief Financial Officer, is scheduled to present on Thursday, June 11, 2009, at 2:30 p.m. Eastern Time.
Martek Biosciences Corporation is a leader in the innovation and development of omega-3 DHA products that promote health and wellness through every stage of life. The Company produces life'sDHA(TM), a vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, infant formula and supplements, and life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com.
Contact: Kyle Stults Investor Relations (410) 740-0081 firstname.lastname@example.org
|SOURCE Martek Biosciences Corporation|
Copyright©2009 PR Newswire.
All rights reserved